Please select the option that best describes you:

What would be your next line of treatment for disease control in a pediatric patient with metastatic hepatocellular carcinoma in partial response after multiple therapies?   

The patient already received PLADO+sorafenib, Y90, and Atezolizumab/Bevacizumab complicated by recurrent episodes of bleeding from esophageal varices. Metastases have resolved and primary tumor has shown partial response to prior treatment.



Answer from: at Academic Institution
Comments
at Lurie Children’s Hospital
Thank you for your reply, Dr. @Arun Rangaswami. To...
Sign in or Register to read more

Answer from: at Community Practice
Sign in or Register to read more